26 June 2025
26 June 2025
Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump administration.
Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.
International vaccine group Gavi raised over $9bn, short of an $11.9bn target it set for a 2026-2030 budget.
LN is a severe complication of lupus, characterised by autoimmune attacks on the kidneys.
The transaction was approved by both companies' boards and includes a significant premium over recent stock prices for Regulus shareholders.
Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
